1. Home
  2. LBRX vs FBIZ Comparison

LBRX vs FBIZ Comparison

Compare LBRX & FBIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LBRX

LB Pharmaceuticals Inc

N/A

Current Price

$23.85

Market Cap

602.6M

Sector

Health Care

ML Signal

N/A

Logo First Business Financial Services Inc.

FBIZ

First Business Financial Services Inc.

HOLD

Current Price

$52.25

Market Cap

485.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LBRX
FBIZ
Founded
2015
1909
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
602.6M
485.9M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
LBRX
FBIZ
Price
$23.85
$52.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$49.00
$65.00
AVG Volume (30 Days)
199.6K
22.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
2.52%
EPS Growth
N/A
14.23
EPS
N/A
5.94
Revenue
N/A
N/A
Revenue This Year
N/A
$15.69
Revenue Next Year
N/A
$8.47
P/E Ratio
N/A
$9.11
Revenue Growth
N/A
N/A
52 Week Low
$13.40
$42.18
52 Week High
$25.60
$60.54

Technical Indicators

Market Signals
Indicator
LBRX
FBIZ
Relative Strength Index (RSI) 51.55 32.73
Support Level $22.48 $46.71
Resistance Level $24.70 $53.63
Average True Range (ATR) 1.31 1.75
MACD -0.18 -0.48
Stochastic Oscillator 43.24 12.23

Price Performance

Historical Comparison
LBRX
FBIZ

About LBRX LB Pharmaceuticals Inc

LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries.

About FBIZ First Business Financial Services Inc.

First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.

Share on Social Networks: